STUDY OBJECTIVES: We have developed the CardioRespiratory Sleep Staging (CReSS) algorithm for estimating sleep stages using heart rate variability and respiration, allowing for estimation of sleep staging during home sleep apnea tests. Our objective was to undertake an epoch-by-epoch validation of algorithm performance against the gold standard of manual polysomnography sleep staging. METHODS: Using 296 polysomnographs, we created a limited montage of airflow and heart rate and deployed CReSS to identify each 30-second epoch as wake, light sleep (N1 + N2), deep sleep (N3), or rapid eye movement (REM) sleep. We calculated Cohen's kappa and the percentage of accurately identified epochs. We repeated our analyses after stratification by sleep-disordered breathing (SDB) severity, and after adding thoracic respiratory effort as a backup signal for periods of invalid airflow. RESULTS: CReSS discriminated wake/light sleep/deep sleep/REM sleep with 78% accuracy; the kappa value was 0.643 (95% confidence interval, 0.641-0.645). Discrimination of wake/sleep demonstrated a kappa value of 0.711 and accuracy of 89%, non-REM sleep/REM sleep demonstrated a kappa of 0.790 and accuracy of 94%, and light sleep/deep sleep demonstrated a kappa of 0.469 and accuracy of 87%. Kappa values did not vary by more than 0.07 across subgroups of no SDB, mild SDB, moderate SDB, and severe SDB. Accuracy increased to 80%, with a kappa value of 0.680 (95% confidence interval, 0.678-0.682), when CReSS additionally utilized the thoracic respiratory effort signal. CONCLUSIONS: We observed substantial agreement between CReSS and the gold-standard comparator of manual sleep staging of polysomnographic signals, which was consistent across the full range of SDB severity. Future research should focus on the extent to which CReSS reduces the discrepancy between the apnea-hypopnea index and the respiratory event index, and the ability of CReSS to identify REM sleep-related obstructive sleep apnea.
STUDY OBJECTIVES: We have developed the CardioRespiratory Sleep Staging (CReSS) algorithm for estimating sleep stages using heart rate variability and respiration, allowing for estimation of sleep staging during home sleep apnea tests. Our objective was to undertake an epoch-by-epoch validation of algorithm performance against the gold standard of manual polysomnography sleep staging. METHODS: Using 296 polysomnographs, we created a limited montage of airflow and heart rate and deployed CReSS to identify each 30-second epoch as wake, light sleep (N1 + N2), deep sleep (N3), or rapid eye movement (REM) sleep. We calculated Cohen's kappa and the percentage of accurately identified epochs. We repeated our analyses after stratification by sleep-disordered breathing (SDB) severity, and after adding thoracic respiratory effort as a backup signal for periods of invalid airflow. RESULTS: CReSS discriminated wake/light sleep/deep sleep/REM sleep with 78% accuracy; the kappa value was 0.643 (95% confidence interval, 0.641-0.645). Discrimination of wake/sleep demonstrated a kappa value of 0.711 and accuracy of 89%, non-REM sleep/REM sleep demonstrated a kappa of 0.790 and accuracy of 94%, and light sleep/deep sleep demonstrated a kappa of 0.469 and accuracy of 87%. Kappa values did not vary by more than 0.07 across subgroups of no SDB, mild SDB, moderate SDB, and severe SDB. Accuracy increased to 80%, with a kappa value of 0.680 (95% confidence interval, 0.678-0.682), when CReSS additionally utilized the thoracic respiratory effort signal. CONCLUSIONS: We observed substantial agreement between CReSS and the gold-standard comparator of manual sleep staging of polysomnographic signals, which was consistent across the full range of SDB severity. Future research should focus on the extent to which CReSS reduces the discrepancy between the apnea-hypopnea index and the respiratory event index, and the ability of CReSS to identify REM sleep-related obstructive sleep apnea.
Authors: Michael H Silber; Sonia Ancoli-Israel; Michael H Bonnet; Sudhansu Chokroverty; Madeleine M Grigg-Damberger; Max Hirshkowitz; Sheldon Kapen; Sharon A Keenan; Meir H Kryger; Thomas Penzel; Mark R Pressman; Conrad Iber Journal: J Clin Sleep Med Date: 2007-03-15 Impact factor: 4.062
Authors: Fábio Mendonça; Sheikh Shanawaz Mostafa; Antonio G Ravelo-García; Fernando Morgado-Dias; Thomas Penzel Journal: Sleep Med Rev Date: 2018-02-17 Impact factor: 11.609
Authors: Jay S Balachandran; Jessie P Bakker; Shilpa Rahangdale; Susie Yim-Yeh; Joseph E Mietus; Ary L Goldberger; Atul Malhotra Journal: Am J Cardiol Date: 2011-09-24 Impact factor: 2.778
Authors: Ilene M Rosen; Douglas B Kirsch; Ronald D Chervin; Kelly A Carden; Kannan Ramar; R Nisha Aurora; David A Kristo; Raman K Malhotra; Jennifer L Martin; Eric J Olson; Carol L Rosen; James A Rowley Journal: J Clin Sleep Med Date: 2017-10-15 Impact factor: 4.062
Authors: Ying Y Zhao; Jia Weng; Daniel R Mobley; Rui Wang; Younghoon Kwon; Phyllis C Zee; Pamela L Lutsey; Susan Redline Journal: J Clin Sleep Med Date: 2017-01-15 Impact factor: 4.062
Authors: Haoqi Sun; Wolfgang Ganglberger; Ezhil Panneerselvam; Michael J Leone; Syed A Quadri; Balaji Goparaju; Ryan A Tesh; Oluwaseun Akeju; Robert J Thomas; M Brandon Westover Journal: Sleep Date: 2020-07-13 Impact factor: 5.849
Authors: Philip Coran; Jennifer C Goldsack; Cheryl A Grandinetti; Jessie P Bakker; Marisa Bolognese; E Ray Dorsey; Kaveeta Vasisht; Adam Amdur; Christopher Dell; Jonathan Helfgott; Matthew Kirchoff; Christopher J Miller; Ashish Narayan; Dharmesh Patel; Barry Peterson; Ernesto Ramirez; Drew Schiller; Thomas Switzer; Liz Wing; Annemarie Forrest; Aiden Doherty Journal: Digit Biomark Date: 2019-11-06
Authors: Doris Moser; Peter Anderer; Georg Gruber; Silvia Parapatics; Erna Loretz; Marion Boeck; Gerhard Kloesch; Esther Heller; Andrea Schmidt; Heidi Danker-Hopfe; Bernd Saletu; Josef Zeitlhofer; Georg Dorffner Journal: Sleep Date: 2009-02 Impact factor: 5.849